美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

2倍做多NVO ETF-Defiance

18.63

-0.2200-1.17%

盤前：18.22-0.4100-2.20%07:18 EST

成交量：39.11萬

成交額：744.54萬

市值：5,250.12萬

市盈率：- -

高：19.64

開：19.29

低：18.52

收：18.85

52周最高：105.60

52周最低：14.59

股本：281.81萬

流通股本：279.81萬

量比：0.21

換手率：13.98%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

德銀：諾和諾德仍有機會重新把握肥胖症市場的機遇

环球市场播报

2026開年大戲：這11個III期臨牀數據，誰會引爆？誰會啞火？

BiG生物创新社

德銀：將諾和諾德目標價下調至400丹麥克朗

減肥藥戰局生變：「雙寡頭」分出高下，全球價格血戰中的國產謀突圍丨行業風向標

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/NVOX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":18.63,"timestamp":1770757200000,"preClose":18.85,"halted":0,"volume":391124,"hourTrading":{"tag":"盘前","latestPrice":18.22,"preClose":18.63,"latestTime":"07:18 EST","volume":2726,"amount":50484.257862,"timestamp":1770812312819,"change":-0.41,"changeRate":-0.022008,"amplitude":0.028986},"delay":0,"changeRate":-0.011671087533156627,"floatShares":2798101,"shares":2818101,"eps":0,"marketStatus":"盤前交易","change":-0.22,"latestTime":"02-11 07:30:24 EST","open":19.29,"high":19.64,"low":18.52,"amount":7445402.045088,"amplitude":0.059416,"askPrice":18.16,"askSize":400,"bidPrice":18.1,"bidSize":1380,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770820200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":18.63,"sharesOutstanding":2798101,"nav":18.82,"aum":52660260.82,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":18.22,"preClose":18.63,"latestTime":"07:18 EST","volume":2726,"amount":50484.257862,"timestamp":1770812312819,"change":-0.41,"changeRate":-0.022008,"amplitude":0.028986},"postHourTrading":{"tag":"盘后","latestPrice":18.58,"preClose":18.63,"latestTime":"19:48 EST","volume":8590,"amount":159548.7515,"timestamp":1770770891644,"change":-0.05,"changeRate":-0.002684,"amplitude":0.009125},"volumeRatio":0.2116692235764067,"impliedVol":0.8922,"impliedVolPercentile":0.5944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOX\",,,,,undefined,":{"symbol":"NVOX","floatShares":2798101,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.2116692235764067,"shares":2818101,"dividePrice":0,"high":19.64,"amplitude":0.059416,"preClose":18.85,"low":18.52,"week52Low":14.5902,"pbRate":"--","week52High":105.6,"institutionHeld":0,"latestPrice":18.63,"committee":0.550562,"eps":0,"divideRate":0,"volume":391124,"delay":0,"ttmEps":0,"open":19.29,"prevYearClose":21.89,"prevWeekClose":17.59,"prevMonthClose":28.89,"prevQuarterClose":21.89,"fiveDayClose":20.05,"twentyDayClose":29.9,"sixtyDayClose":22.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-12-09","symbol":"NVOX","defaultRemindTime":1765290600000,"type":"split","dateTimestamp":1765256400000,"forFactor":8,"toFactor":1,"ratio":8}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610935665","title":"德銀：諾和諾德仍有機會重新把握肥胖症市場的機遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2610935665","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610935665?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 18:28","pubTimestamp":1770805680,"startTime":"0","endTime":"0","summary":"德意志银行分析师Emmanuel Papadakis写道，诺和诺德在适当的时候仍有机会重新把握其在肥胖症市场的机遇。该行仍对诺和诺德持乐观看法，该股市盈率已回落至十几倍的水平。　　该公司Wegovy口服药的上市表现稳健，下半年有潜在的销量利好因素，而且或许最重要的是，关键的cagrisema数据仍有待公布。　　该行将该股目标价从475丹麦克朗下调至400丹麦克朗，并维持买入评级。该股下跌2.4%，至307.55丹麦克朗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-11/doc-inhmmvza3702737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4588","NVOX","NVOH","BK4532","IE00BKVL7J92.USD","LU0154236417.USD","BK4599","NVO","BK4007","LU1093756168.USD","BK4585"],"gpt_icon":0},{"id":"2610677932","title":"2026開年大戲：這11個III期臨牀數據，誰會引爆？誰會啞火？","url":"https://stock-news.laohu8.com/highlight/detail?id=2610677932","media":"BiG生物创新社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610677932?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 17:45","pubTimestamp":1770803139,"startTime":"0","endTime":"0","summary":"作者｜YY2026年第一季度将集中披露多项处于3期的关键临床读数，这些结果直接关系核心资产的推进路径，也已被市场纳入当前估值体系之中。该信息公布当日，Alumis股价 上涨约155%至21美元，公司市值增加约13亿美元，创历史新高。关键临床读数COMP006是一项国际多中心、随机、双盲、平行分组的注册性III期研究，9周顶线数据预计将于2026年第一季度披露，评估抑郁症状改善的持续性。最新的官方预期是在2026年2月公布24周的主要终点顶线数据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211191533a6eec760&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211191533a6eec760&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","NVOX","BK4007","BK4599","LU0154236417.USD","IE00BKVL7J92.USD","NVOH","BK4134","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD","NVO","NVS","BK4588","LU1093756168.USD","BK4532"],"gpt_icon":0},{"id":"2610098986","title":"德銀：將諾和諾德目標價下調至400丹麥克朗","url":"https://stock-news.laohu8.com/highlight/detail?id=2610098986","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610098986?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 15:30","pubTimestamp":1770795023,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1093756168.USD","BK4599","LU1093756325.SGD","NVO","BK4588","BK4585","NVOH","IE00BZ1G4Q59.USD","BK4532","IE00BKVL7J92.USD","LU0154236417.USD","NVOX","BK4007"],"gpt_icon":0},{"id":"2610198552","title":"減肥藥戰局生變：「雙寡頭」分出高下，全球價格血戰中的國產謀突圍丨行業風向標","url":"https://stock-news.laohu8.com/highlight/detail?id=2610198552","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610198552?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 14:01","pubTimestamp":1770789670,"startTime":"0","endTime":"0","summary":"2月9日，诺和诺德宣布对远程医疗公司Hims提起专利侵权诉讼。礼来也公开支持FDA行动，谴责非法仿制药对患者健康的危害。在专利战爆发的同时，FDA对诺和诺德的双面监管则更具深意。FDA要求诺和诺德15个工作日内提交整改方案，否则将限制产品推广。中国市场成必争之地随着GLP-1减肥药的竞争进入深水区，价格战已从欧美市场蔓延至全球，而中国市场成为巨头角力的关键阵地，国产药企则在仿制药与创新药两条赛道上加速突围。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211141535a6ed962b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211141535a6ed962b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVOH","NVOX","BK4585","BK4007","NVO","BK4588","LLY","BK4532","LU1093756168.USD","LU1093756325.SGD","BK4599","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD"],"gpt_icon":0}],"pageSize":4,"totalPage":18,"pageCount":1,"totalSize":69,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NVOX\",params:#limit:6,delay:false,,,undefined,":[]}}